Outlook Therapeutics
$0.7199876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.
$0.719
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
+$0.0233 (+3.35%) As of 12:57 PM EDT today
Why Robinhood?
You can buy or sell OTLK and other stocks, options, ETFs, and crypto commission-free!
About OTLK
Outlook Therapeutics, Inc. Common Stock, also called Outlook Therapeutics, is a clinical-stage biopharmaceutical company. Read More The firm engages in the identification, development, manufacture, and commercialization of complex biosimilar therapeutics. It focuses on monoclonal antibodies, in the disease areas of immunology and oncology. The company was founded by Pankaj Mohan on January 5, 2010 and is headquartered in Cranbury, NJ.
Employees
14
Headquarters
South Brunswick, New Jersey
Founded
2010
Market Cap
92.97M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
1.45M
High Today
$0.74
Low Today
$0.7041
Open Price
$0.7099
Volume
719.62K
52 Week High
$1.76
52 Week Low
$0.499
Collections
OTLK Earnings
-$0.62
-$0.40
-$0.17
$0.05
Q1 2019
Q2 2019
Q3 2019
Q4 2019
Q1 2020
Q2 2020
Q3 2020
Q4 2020
Estimated
— per share
Actual
Expected Dec 17, Pre-Market